Over the past 20 years, the company has taken the road of cooperation in Industry-University-Research, and successively developed a variety of advanced enzyme preparation products, such as pancreatic kininogenase, elastase, L- asparaginase, compound digestive enzyme, etc., which filled the gap in China. Especially, pancreatic kininogenase was used to prevent and treat diabetic complications for the first time in the world, and it was successful, thus laying a competitive foundation in this field. In order to strengthen scientific research, the company established the "Changzhou Biopharmaceutical Engineering Technology Center" in cooperation with the School of Biopharmacy of China Pharmaceutical University, which is dedicated to the research and development of large-scale drugs such as natural drugs, chemically synthesized drugs and genetically engineered drugs. At present, new drugs and anti-chemotherapy drugs with independent intellectual property rights are being developed, and great progress has been made in pharmacological and clinical research. The Institute of Human Stem Cell Engineering, a joint venture with Nanjing University School of Medicine, is entering the high-tech field of producing and selling human stem cell products. After years of efforts, the key variety heparin sodium has taken the lead in passing COS field certification and drug virus detection in China. The internal quality standard of the key variety Yi Kai has been upgraded to the national pharmacopoeia standard by the National Pharmacopoeia Committee, which enjoys a high reputation at home and abroad.
In recent years, the company has been implementing the business strategy of scale and first-class products, and strives to open up domestic and foreign markets. The sales network covers 29 provinces (cities) and regions in China, as well as Germany, Italy, the United States, Japan, South Korea, India, Brazil and other countries. Market size promotes rapid economic development. In recent years, the company's strength has been continuously improved, its benefits have increased year by year, and its product sales and profits have continued to grow at a relatively fast rate.